BRIEF-Rigel restructures to focus on Fostamatinib commercialization By: Reuters: Company News September 15, 2016 at 08:02 AM EDT * Rigel restructures to focus on fostamatinib commercialization Read More >> Related Stocks: Rigel Pharmaceuticals